Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Fascin actin-bundling protein 3 (FSCN3) is a member of the fascin family of small, globular actin-bundling proteins with four β-trefoil domains, each containing distinct actin-binding sites[2][3][4]. Fascin proteins organize actin filaments into tightly packed, well-ordered bundles that support membrane protrusions (filopodia, microspikes, invadopodia) involved in cell motility, migration, and invasion[1][2][3]. Fascin-3 has tissue-specific expression, primarily in the testis, where it is thought to play a role in spermatogenesis and the formation of cytoskeletal structures essential for sperm development. Dysregulation of fascin proteins (especially fascin-1) is implicated in cancer metastasis and is being investigated as a therapeutic target; inhibitors such as G2 disrupt actin bundling by interfering with fascin’s actin-binding sites[3]. Fascin proteins, including fascin-3, bind actin filaments through two major actin-binding sites and may dimerize for bundling activity[2][3][4].\n\nIf you need more information specific to fascin-3's testicular roles or related disease associations, further literature review on FSCN3 is recommended. If your context was fascin-1 (the most well-studied isoform in cancer), please clarify, as much research and drug targeting focuses on fascin-1[2][3].
Allosteric inhibition of actin bundling by fascin inhibitors (e.g., G2 disrupts F-actin cross-linking by binding fascin and blocking actin-binding interfaces[3].)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Fascin actin-bundling protein 3 (FSCN3).